HKAPI has announced the election of two new members to its Board of Directors. Mr Neo Lam, from Baxter, and Mr Jonathan Chin, from Boehringer Ingelheim, have been elected to join the Board and will serve until the end of this term (2024).
The 1st CEO Meeting of the Term (2022-24) was held online on 11 July 2022. More than 20 CEOs and directors from our member companies joined to meet the new HKAPI Board, and exchanged views on the future directions of the Association.
The Hong Kong Association of The Pharmaceutical Industry held its 54th Annual General Meeting on 30 March 2022 and delighted to announce the formation of the New Board (2022-2024) with the following members: